Vericel Stock

Vericel EBIT per Employee

The EBIT per Employee of Vericel (VCEL) as of Aug 16, 2026 is 45,825.73 USD. In the previous year, EBIT per Employee was 18,751.04 USD — a change of 144.39% (higher).

EBIT per Employee

45,825.73USD

YoY

144.39%

Last updated:

EBIT per Employee of Vericel is 2026 45,825.73 USD. EBIT per Employee of Vericel was 2025 18,751.04 USD. It decreases by 144.39% higher compared to the previous year.
Access this data via the Eulerpool API

Vericel Stock analysis

What does Vericel do? Vericel Corp is a US biotechnology company specializing in the development and commercialization of innovative cell therapies for patients with serious diseases. The company is headquartered in Cambridge, Massachusetts and was founded in 1997. Vericel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vericel stock

EBIT per Employee of Vericel is 45,825.73 USD in 2026.

EBIT per Employee of Vericel changed from 18,751.04 USD to 45,825.73 USD, representing a 144.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Vericel since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Vericel historically and in real time.

Access this data via the Eulerpool API

Workforce — Vericel

All Key Metrics — Vericel